Veru Share Price

Veru Share Price

NASDAQ: VERU | Micro Cap | Healthcare
$1.94
-$0.18 (-8.51%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Veru Stock Performance

Open
$2.15
Prev. Close
$2.12
Circuit Range
N/A
Day Range
$1.93 - $2.15
Year Range
$1.93 - $7.23
Volume
5,483
Average Traded
$2.01

Veru Share Price Today

As of 21 November 2026, Veru Inc.'s share price is $1.94. The stock opened at $2.15, compared to its previous close of $2.12. During today's trading session, Veru Inc.'s share price traded between $1.93 and $2.15, with an average price of $2.04. Over the past 52 weeks, the stock has recorded a high of $7.23 and a low of $1.93. In terms of performance, Veru Inc.'s share price has declined by 17.83% over the last six months and is down 21.98% on a year-on-year basis.

Veru Share Price Chart

Line chart of the Veru price trend over the selected period. The price fell overall, ranging from 1.93 to 2.15, ending at 1.94.
$1.93$2.15
L
Show Current Price
H

Veru Stock Fundamentals & Key Indicators

Market Cap
$28.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.80
Revenue (TTM)
$0.00
Return On Equity (TTM)
-47.96%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-582.07%

Veru Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$1.45-$5.33-$2.74-$6.99
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-467.59%48.59%-155.11%

Veru Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$39.35$16.30$0.00$0.00
Net Profit-$83.78-$93.15-$37.80-$22.73
Net Profit Margin-212.91%-571.47%N/AN/A
Income ChangeN/A-11.18%59.42%39.87%

Veru Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets10.9225.227.0931.36
Current Assets18.9235.2222.93104.77
Total Assets29.8460.4250.02136.13
Non Current Liabilities3.7218.912.5313.85
Current Liabilities7.799.217.8141.44
Total Liabilities11.528.130.3455.29
Shareholders' Equity18.3332.3219.6880.84

Veru Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-30.04-21.68-88.01-47.51
Investing25.140.156.334.27
Financing-4.2236.8311.111.07

Corporate Actions

Split
Ex-date: 11 Aug 2025

About Veru

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Veru Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.19
$1.94
-12.05%
Oct 2026
$2.61
$2.20
-17.76%
Sep 2026
$2.82
$2.67
-2.73%
Aug 2026
$2.26
$2.75
+23.04%
Jul 2026
$3.15
$2.23
-28.82%
Jun 2026
$2.28
$3.14
+33.33%
May 2026
$2.26
$2.35
+4.20%
Apr 2026
$2.30
$2.26
+1.35%
Mar 2026
$2.50
$2.23
-12.55%
Feb 2026
$2.54
$2.55
+0.79%
Jan 2026
$2.18
$2.53
+18.78%
Dec 2025
$2.48
$2.13
-14.11%

Veru Share Price FAQs